{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T08:13:57Z","timestamp":1788682437803,"version":"build-2803163510"},"reference-count":15,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2005,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>\n                    Overlapping peptides of\n                    <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                    antigens ESAT-6 and CFP-10 offer increased specificity over the purified protein derivative skin test when they were used in an ex vivo enzyme-linked immunospot (ELISPOT) assay for gamma interferon detection for the diagnosis of\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    infection from recent exposure. We assessed whether equivalent results could be obtained for a fusion protein of the two antigens and whether a combined readout would offer increased sensitivity in The Gambia. We studied the ELISPOT assay results for 488 household contacts of 88 sputum smear-positive tuberculosis (TB) cases. The proportions of subjects positive by each test and by the tests combined were assessed across an exposure gradient, defined according to sleeping proximity to a TB case. Eighty-eight (18%) subjects were positive for CFP-10 peptides, 148 (30%) were positive for ESAT-6 peptides, 161 (33%) were positive for both peptides, and 168 (34%) were positive for the fusion protein; 188 (39%) subjects had either a positive result for a peptide or a positive result for the fusion protein. There was reasonable agreement between the peptide and the protein results (kappa statistic = 0.78) and no significant discordance (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.38). There was a strong correlation between the fusion protein and combined peptide spot counts (\n                    <jats:italic>r<\/jats:italic>\n                    = 0.9), and responses to the peptide and the proteins all increased significantly according to\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    exposure. The proportion of subjects positive for either the pool of peptides or the fusion protein offered maximum sensitivity, being significantly higher than the proportion of subjects positive for ESAT-6 peptides alone (\n                    <jats:italic>P<\/jats:italic>\n                    = 0.007). A fusion protein of ESAT-6 and CFP-10 is equivalent to overlapping peptides for the diagnosis of latent\n                    <jats:italic>M. tuberculosis<\/jats:italic>\n                    infection. Use of a combination of peptides and fusion protein offers improved sensitivity.\n                  <\/jats:p>","DOI":"10.1128\/jcm.43.5.2070-2074.2005","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T18:33:14Z","timestamp":1115231594000},"page":"2070-2074","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":52,"title":["ESAT-6\/CFP-10 Fusion Protein and Peptides for Optimal Diagnosis of\n                    <i>Mycobacterium tuberculosis<\/i>\n                    Infection by Ex Vivo Enzyme-Linked Immunospot Assay in The Gambia"],"prefix":"10.1128","volume":"43","author":[{"given":"Philip C.","family":"Hill","sequence":"first","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dolly","family":"Jackson-Sillah","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Fox","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kees L. M. C.","family":"Franken","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses D.","family":"Lugos","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Jeffries","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon A.","family":"Donkor","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulrahman S.","family":"Hammond","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Adegbola","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom H. M.","family":"Ottenhoff","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger H.","family":"Brookes","sequence":"additional","affiliation":[{"name":"Tuberculosis Division, Bacterial Diseases Programme, Medical Research Council Unit, Banjul, The Gambia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1086\/315448"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/CDLI.8.6.1089-1096.2001"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2404004"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1099\/00221287-144-11-3195"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200211220-00008"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1006\/prep.1999.1162"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature02240"},{"key":"e_1_3_2_9_2","first-page":"85","year":"1994","unstructured":"Heifets, L. B., and R. B. Good. 1994. Current laboratory methods for the diagnosis of tuberculosis, p. 85-110. In B. R. Bloom (ed.), Tuberculosis: protection, pathogenesis, and control. American Society for Microbiology, Washington, DC.","journal-title":"Tuberculosis: protection, pathogenesis, and control"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1086\/382362"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.186.6.859"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1086\/318081"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M201625200"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02724-0"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199812)28:12<3949::AID-IMMU3949>3.0.CO;2-4"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1095522"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.5.2070-2074.2005","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.43.5.2070-2074.2005","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T23:07:37Z","timestamp":1646435257000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.43.5.2070-2074.2005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["10.1128\/JCM.43.5.2070-2074.2005"],"URL":"https:\/\/doi.org\/10.1128\/jcm.43.5.2070-2074.2005","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5]]},"assertion":[{"value":"2004-12-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-01-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2005-05-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}